Getagraph.com logo
NASDAQ Composite: ( -0.07%) 16 686
S&P 500 Futures
(0.11%) 5 333.25 points
Dow Jones Futures
(0.03%) 40 148 points
Nasdaq Futures
(0.19%) 18 670 points
Oil
(-0.21%) $79.89
Gas
(0.91%) $2.65
Gold
(0.97%) $2 440.90
Silver
(2.64%) $32.09
Platinum
(0.14%) $1 091.50
USD/EUR
(-0.02%) $0.920
USD/NOK
(-0.05%) $10.67
USD/GBP
(0.04%) $0.787
USD/RUB
(-0.49%) $90.52

Realtime updates for Insmed Inc [INSM]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
62.50%
return 7.26%
SELL
50.00%
return 4.38%
Last Updated17 May 2024 @ 16:00
25% discount on Stockinvest.us - Use code: Podcast

-1.31% $ 24.77

BUY 117864 min ago

@ $28.97

Issued: 28 Feb 2024 @ 09:30

Return: -14.50%

Previous signal: Feb 27 - 15:07

Previous signal: Sell

Return: -1.16 %

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients...

Stats
Today's Volume 2.59M
Average Volume 1.78M
Market Cap 3.68B
EPS $0 ( 2024-05-09 )
Next earnings date ( $-1.130 ) 2024-08-01
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -4.74
ATR14 $0.0270 (0.11%)
Insider Trading
Date Person Action Amount type
2024-05-17 Flammer Martina M.d. Sell 4 642 Common Stock
2024-05-17 Adsett Roger Sell 5 945 Common Stock
2024-05-13 Wise John Drayton Buy 14 518 Common Stock
2024-05-14 Wise John Drayton Sell 5 088 Common Stock
2024-05-13 Wise John Drayton Buy 71 160 Stock Option (right to buy)
INSIDER POWER
60.64
Last 100 transactions
Buy: 1 905 314 | Sell: 513 651

Volume Correlation

Long: -0.26 (neutral)
Short: 0.01 (neutral)
Signal:(54.526) Neutral

Insmed Inc Correlation

10 Most Positive Correlations
QLGN0.865
CFFI0.861
CRSR0.858
CSIQ0.854
LIND0.845
VS0.844
TXG0.843
PACB0.843
RICK0.843
APVO0.843
10 Most Negative Correlations
BSCO-0.862
IGTA-0.836
ALPN-0.831
ENTX-0.826
RVMD-0.824
MDWD-0.824
ARYD-0.815
JAN-0.815
AEAE-0.814
NKTR-0.81

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Insmed Inc Correlation - Currency/Commodity

The country flag 0.09
( neutral )
The country flag -0.21
( neutral )
The country flag 0.00
( neutral )
The country flag 0.49
( neutral )
The country flag 0.05
( neutral )
The country flag 0.00
( neutral )

Insmed Inc Financials

Annual 2023
Revenue: $305.21M
Gross Profit: $239.64M (78.52 %)
EPS: $-5.34
FY 2023
Revenue: $305.21M
Gross Profit: $239.64M (78.52 %)
EPS: $-5.34
FY 2022
Revenue: $245.36M
Gross Profit: $190.23M (77.53 %)
EPS: $-3.91
FY 2021
Revenue: $188.46M
Gross Profit: $144.31M (76.57 %)
EPS: $-3.88

Financial Reports:

No articles found.

Insmed Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Insmed Inc

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators